Dataset from Randomized, Double Blind, Placebo-Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006841
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the efficacy and safety of Icatibant, a bradykinin
antagonist in the treatment of acute cutaneous and/or abdominal attacks in patients with
hereditary angioedema (HAE).
创建时间：
2024-11-26
